Ubs Asset Management Americas Inc Kymera Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $477 Billion
  • Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 818,927 shares of KYMR stock, worth $50.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
818,927
Previous 896,404 8.64%
Holding current value
$50.3 Million
Previous $24.5 Million 45.66%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$21.05 - $48.6 $1.63 Million - $3.77 Million
-77,477 Reduced 8.64%
818,927 $35.7 Million
Q1 2025

May 19, 2025
BUY
$27.37 - $44.36 $13.5 Million - $21.8 Million
491,737 Added 121.52%
896,404 $24.5 Million
Q4 2024

Feb 14, 2025
SELL
$39.06 - $51.84 $932,049 - $1.24 Million
-23,862 Reduced 5.57%
404,667 $16.3 Million
Q3 2024

Nov 14, 2024
SELL
$30.16 - $52.4 $152,127 - $264,305
-5,044 Reduced 1.16%
428,529 $20.3 Million
Q2 2024

Aug 13, 2024
BUY
$29.85 - $39.42 $7.57 Million - $10 Million
253,635 Added 140.96%
433,573 $12.9 Million
Q1 2024

May 15, 2024
BUY
$22.9 - $43.57 $78,730 - $149,793
3,438 Added 1.95%
179,938 $7.23 Million
Q4 2023

Feb 14, 2024
SELL
$10.97 - $26.84 $145,166 - $355,173
-13,233 Reduced 6.97%
176,500 $4.49 Million
Q3 2023

Nov 13, 2023
BUY
$13.9 - $23.88 $183,549 - $315,335
13,205 Added 7.48%
189,733 $2.64 Million
Q1 2023

May 15, 2023
SELL
$24.84 - $38.75 $75,488 - $117,761
-3,039 Reduced 1.69%
176,528 $5.23 Million
Q4 2022

Feb 14, 2023
BUY
$19.57 - $30.92 $235,270 - $371,720
12,022 Added 7.18%
179,567 $4.48 Million
Q3 2022

Nov 14, 2022
SELL
$20.91 - $34.27 $559,948 - $917,716
-26,779 Reduced 13.78%
167,545 $3.65 Million
Q2 2022

Aug 12, 2022
SELL
$14.13 - $42.55 $3.33 Million - $10 Million
-235,919 Reduced 54.83%
194,324 $3.83 Million
Q1 2022

May 16, 2022
BUY
$35.3 - $64.68 $5.8 Million - $10.6 Million
164,192 Added 61.71%
430,243 $18.2 Million
Q4 2021

Feb 14, 2022
SELL
$49.91 - $65.56 $11,878 - $15,603
-238 Reduced 0.09%
266,051 $16.9 Million
Q3 2021

Nov 15, 2021
SELL
$47.8 - $66.66 $752,850 - $1.05 Million
-15,750 Reduced 5.58%
266,289 $15.6 Million
Q2 2021

Aug 16, 2021
BUY
$31.08 - $51.95 $8.77 Million - $14.7 Million
282,039 New
282,039 $13.7 Million

Others Institutions Holding KYMR

# of Institutions
222
Shares Held
72.3M
Call Options Held
178K
Put Options Held
64.6K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $3.36B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email